Breast Surgery Practice Questions

Q: Stage T1N0M0 in breast cancer indicates:

Tumor 2 cm or less without axillary nodes and no metastasis. ### Explanation The staging of breast cancer follows the **AJCC TNM Classification** (Tumor, Node, Metastasis), which is a critical high-yield topic for NEET-PG. **1. Why the Correct Answer is Right:** * **T1:** Refers to a tumor that is **2 cm or less** in its greatest dimension. * **N0:** Indicates that there is **no regional lymph node metastasis** (clinically or pathologically). * **M0:** Indicates that there is **no distant metastasis**. Therefore, T1N0M0 represents an early-stage breast cancer (Stage IA) where the primary lesion is small and localized. **2. Analysis of Incorrect Options:** * **Option A:** A tumor **more than 2 cm** would be classified as **T2** (if 2–5 cm) or **T3** (if >5 cm). * **Option C:** Fixation to the **chest wall** (ribs, intercostals, or serratus anterior) automatically classifies the tumor as **T4a**, regardless of size. * **Option D:** Fixation to the underlying muscle (Pectoralis) does not change the T-stage unless it involves the chest wall, but the presence of **distant metastasis** makes it **M1 (Stage IV)**, regardless of T or N status. **3. Clinical Pearls for NEET-PG:** * **T1 Subdivisions:** T1mi (≤0.1 cm), T1a (>0.1 to 0.5 cm), T1b (>0.5 to 1 cm), and T1c (>1 to 2 cm). * **T4 Categories:** T4a (Chest wall), T4b (Skin edema/Peau d'orange/Ulceration), T4c (Both 4a & 4b), T4d (Inflammatory carcinoma). * **Stage IA vs. IB:** Stage IA is T1N0M0. Stage IB involves micrometastasis in lymph nodes (T0/T1, N1mi, M0). * **Management:** T1N0M0 is typically managed with Breast Conservation Surgery (BCS) or Modified Radical Mastectomy (MRM) followed by appropriate adjuvant therapy.

Q: Which myocutaneous flap is considered the best for reconstruction surgery in breast carcinoma?

Transverse rectus abdominis. **Explanation:** The **Transverse Rectus Abdominis Myocutaneous (TRAM) flap** is considered the "gold standard" for autologous breast reconstruction. **Why TRAM is the best choice:** The primary goal of breast reconstruction is to provide adequate volume, natural contour, and skin coverage. The TRAM flap utilizes the skin and subcutaneous fat from the lower abdomen (the "tummy tuck" area), which closely mimics the consistency and volume of natural breast tissue. It can be performed as a **pedicled flap** (based on the superior epigastric artery) or a **free flap** (based on the deep inferior epigastric artery). Its ability to provide a large amount of tissue without the need for synthetic implants makes it the preferred choice for most surgeons. **Analysis of Incorrect Options:** * **Pectoralis major/minor:** These are muscles of the chest wall. While the Pectoralis major is often used to provide muscular coverage for a breast *implant* (subpectoral placement), it does not provide the bulk or skin required for a complete autologous reconstruction. * **Latissimus dorsi (LD) flap:** This was historically common but is now generally considered second-line. The LD muscle is thin and often requires an additional silicone implant to achieve sufficient breast volume, unlike the TRAM flap which is usually "implant-independent." **High-Yield Clinical Pearls for NEET-PG:** * **Blood Supply:** The pedicled TRAM flap is based on the **Superior Epigastric Artery**, while the free TRAM/DIEP flap is based on the **Deep Inferior Epigastric Artery**. * **DIEP Flap:** The Deep Inferior Epigastric Perforator (DIEP) flap is a refinement of the TRAM that spares the rectus muscle, reducing the risk of abdominal wall hernia. * **Contraindication:** TRAM flaps are generally avoided in patients with significant prior abdominal surgeries (e.g., extensive abdominoplasty) or heavy smokers due to compromised microvasculature.

Q: A discrete breast lump without tenderness is most likely found in an 18-year-old female. What is the most likely diagnosis?

Fibroadenoma. **Explanation:** The clinical presentation of a **discrete, non-tender breast lump** in a young female (typically between 15–30 years) is the classic hallmark of a **Fibroadenoma**. **Why Fibroadenoma is correct:** Fibroadenomas are the most common benign tumors of the female breast. They arise from the terminal duct lobular unit due to increased sensitivity to estrogen. Characteristically, they are firm, smooth, rubbery, and highly mobile—earning them the clinical nickname **"Breast Mouse"** because they slip away under the examining fingers. **Why other options are incorrect:** * **Fibroadenosis (Fibrocystic changes):** This typically presents as ill-defined, "lumpy" breast tissue rather than a discrete mass. It is often bilateral and associated with cyclical pain (mastalgia) that worsens before menstruation. * **Carcinoma of the breast:** While possible, it is extremely rare in an 18-year-old. Malignant lumps are usually hard, irregular, fixed to skin or underlying muscle, and painless. * **Mastalgia:** This refers to breast pain itself, not a physical lump. While it can coexist with other conditions, it is a symptom, not a diagnosis for a discrete mass. **High-Yield NEET-PG Pearls:** * **Triple Assessment:** The gold standard for diagnosis includes Clinical Examination, Imaging (Ultrasound for 30 years), and Pathology (FNAC or Core Needle Biopsy). * **Management:** If the lump is small ( 3 cm (Giant Fibroadenoma), or if the patient is anxious. * **Histology:** Shows a biphasic proliferation of both epithelial and stromal components. Patterns can be intracanalicular or pericanalicular.

Q: A 40-year-old female, chronic smoker, presented to the surgical department with a reddish, painful subareolar mass in the right breast. What is the most likely diagnosis?

Periductal mastitis. **Explanation:** **Periductal Mastitis (Zuska’s Disease)** is the most likely diagnosis. The classic presentation involves a **subareolar** inflammatory mass in a **young to middle-aged woman** with a significant history of **smoking**. 1. **Why it is correct:** Smoking is the primary risk factor. It causes squamous metaplasia of the lactiferous ducts, leading to keratin plugging, ductal ectasia, and secondary infection. This results in the characteristic painful, erythematous subareolar mass. If left untreated, it often progresses to a periareolar abscess or a mammary duct fistula. 2. **Why the other options are incorrect:** * **Carcinoma Breast:** While a mass in a 40-year-old must be investigated, inflammatory breast cancer usually presents with a more diffuse "peau d'orange" appearance rather than a localized subareolar mass, and it is typically not associated specifically with smoking. * **Fat Necrosis:** This usually follows a history of trauma or surgery. While it can present as a firm mass with skin tethering, it is generally painless and lacks the acute inflammatory signs (redness/pain) seen here. * **Granulomatous Mastitis:** This typically occurs in parous women (often within a few years of childbirth) and presents as peripheral, multiple, or "multicentric" inflammatory lobular masses rather than a localized subareolar lesion. **Clinical Pearls for NEET-PG:** * **The "Smoking" Link:** In any breast surgery question, **Smoking + Subareolar Mass = Periductal Mastitis.** * **Management:** Initial treatment involves antibiotics (covering anaerobes like *Bacteroides*). Recurrent cases require the **Hadfield’s procedure** (total excision of the major duct system). * **Pathology:** Look for "squamous metaplasia of lactiferous ducts" in the biopsy description.

Q: What is the most important prognostic factor of carcinoma breast?

Lymph node involvement. ### Explanation In breast carcinoma, the **axillary lymph node status** is the single most important and reliable independent prognostic factor. It reflects the biological behavior of the tumor and its potential for systemic spread. The number of involved nodes directly correlates with the risk of recurrence and overall survival; for instance, patients with more than 10 positive nodes have a significantly poorer prognosis compared to those with 1–3 nodes. **Analysis of Options:** * **A. Lymph node involvement (Correct):** It is the most significant predictor of disease-free and overall survival. It dictates the staging (TNM) and the necessity for adjuvant systemic therapy. * **B. DNA content of tumor:** While aneuploidy (abnormal DNA content) is associated with aggressive behavior, it is a secondary prognostic marker and less reliable than nodal status. * **C. Histologic subtype:** Certain subtypes (e.g., medullary or tubular) have better outcomes than Invasive Ductal Carcinoma (NOS), but nodal status remains a more powerful predictor within these categories. * **D. Tumor grade:** Histological grading (Nottingham/Scarff-Bloom-Richardson system) assesses aggressiveness, but it is considered the *second* most important prognostic factor after lymph node status. **High-Yield Clinical Pearls for NEET-PG:** * **Most important prognostic factor:** Axillary lymph node status. * **Second most important prognostic factor:** Tumor size (T) or Tumor Grade. * **Most important factor for deciding adjuvant chemotherapy:** Axillary lymph node status. * **Sentinel Lymph Node Biopsy (SLNB):** The gold standard for axillary staging in clinically N0 (node-negative) patients. * **Triple Negative Breast Cancer (TNBC):** Carries the worst prognosis among molecular subtypes due to lack of targeted therapy options.

Q: What is the most important prognostic factor of carcinoma breast?

Lymph node involvement. ### Explanation **Correct Option: A. Lymph node involvement** In breast carcinoma, the **axillary lymph node status** is the single most important and powerful independent prognostic factor. It reflects the biological behavior of the tumor and its potential for systemic spread. The number of involved nodes directly correlates with disease-free and overall survival: patients with no nodal involvement have a 10-year survival rate of approximately 70-80%, which drops significantly as the number of positive nodes increases (especially >4 nodes). **Analysis of Incorrect Options:** * **B. DNA content of tumor:** While aneuploidy (abnormal DNA content) is associated with a poorer prognosis, it is a molecular marker and lacks the clinical predictive power of anatomical staging like nodal status. * **C. Histologic subtype:** Certain subtypes (e.g., medullary, mucinous, or tubular) have a better prognosis than the common Invasive Ductal Carcinoma (IDC). However, within any subtype, the nodal status remains the primary determinant of outcome. * **D. Tumor grade:** Histological grading (e.g., Nottingham Grading System) assesses tubule formation, nuclear pleomorphism, and mitotic count. While it indicates tumor aggressiveness, it is secondary to the anatomical extent (Stage) of the disease. **High-Yield Clinical Pearls for NEET-PG:** * **Most important prognostic factor:** Axillary lymph node status. * **Second most important prognostic factor:** Tumor size (T stage). * **Most important factor for deciding Adjuvant Therapy:** Axillary lymph node status. * **Sentinel Lymph Node Biopsy (SLNB):** The gold standard for axillary staging in clinically N0 (node-negative) patients. * **Triple Negative Breast Cancer (TNBC):** Carries the worst prognosis among molecular subtypes due to the lack of targeted therapy options.

Question 1

Stage T1N0M0 in breast cancer indicates:

Accepted Answer

Tumor 2 cm or less without axillary nodes and no metastasis

Answer

Tumor more than 2 cm in diameter without axillary nodes and absent metastasis

Answer

Tumor fixed to the chest wall without axillary nodes or distant metastasis

Answer

Tumor fixed to the underlying muscle with no nodes in axilla but with distant metastasis

Question 2

Which myocutaneous flap is considered the best for reconstruction surgery in breast carcinoma?

Accepted Answer

Transverse rectus abdominis

Answer

Pectoralis minor

Answer

Pectoralis major

Answer

Latissimus dorsi

Question 3

Regarding the established risk factors for breast cancer, all are true, EXCEPT:

Accepted Answer

Prior breast biopsy of benign breast disease is associated with a decreased risk of breast cancer

Answer

Occurrence in Indian women is about a decade earlier than in western women

Answer

Breast cancer is common in higher socioeconomic groups

Answer

40 or more years of menstruation doubles the risk of breast cancer as compared with 30 years

Question 4

A discrete breast lump without tenderness is most likely found in an 18-year-old female. What is the most likely diagnosis?

Accepted Answer

Fibroadenoma

Answer

Fibroadenosis

Answer

Carcinoma of the breast

Answer

Mastalgia

Question 5

Consider the following statements regarding Paget's disease of the breast:

Accepted Answer

Treatment of choice is simple mastectomy.

Answer

It is a malignant disease.

Answer

Diagnosis can be established by scrape cytology.

Answer

Lymph node involvement is an associated clinical feature.

Question 6

Which of the following indicates carcinoma of the breast?

Accepted Answer

Recent retraction of the nipple

Answer

Ulceration of the nipple

Answer

Cracked nipple

Answer

Serous discharge

Question 7

A 40-year-old female, chronic smoker, presented to the surgical department with a reddish, painful subareolar mass in the right breast. What is the most likely diagnosis?

Accepted Answer

Periductal mastitis

Answer

Carcinoma breast

Answer

Fat necrosis

Answer

Granulomatous mastitis

Question 8

Which of the following statements is true regarding triple-negative breast cancer?

Accepted Answer

Three radiologic investigations, namely CT scan, MRI, and USG, are needed for diagnosis.

Answer

It has a good prognosis.

Answer

There are no receptors positive for ER, PR, and HER2/neu.

Answer

It is a cancer that cannot be diagnosed by triple assessment.

Question 9

What is the most important prognostic factor of carcinoma breast?

Accepted Answer

Lymph node involvement

Answer

DNA content of tumor

Answer

Histologic subtype

Answer

Tumor grade

Question 10

What is the most important prognostic factor of carcinoma breast?

Accepted Answer

Lymph node involvement

Answer

DNA content of tumor

Answer

Histologic subtype

Answer

Tumor grade

Breast Surgery — MCQs

Breast Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?